Entrada Therapeutics Inc banner

Entrada Therapeutics Inc
NASDAQ:TRDA

Watchlist Manager
Entrada Therapeutics Inc Logo
Entrada Therapeutics Inc
NASDAQ:TRDA
Watchlist
Price: 12.5 USD 5.49% Market Closed
Market Cap: $477.8m

Intrinsic Value

The intrinsic value of one TRDA stock under the Base Case scenario is 4.37 USD. Compared to the current market price of 12.5 USD, Entrada Therapeutics Inc is Overvalued by 65%.

TRDA Intrinsic Value
4.37 USD
Overvaluation 65%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Entrada Therapeutics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about TRDA?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is TRDA valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Entrada Therapeutics Inc.

Explain Valuation
Alternatives to TRDA

Fundamental Analysis

Financials
Efficiency

Earnings Waterfall
Entrada Therapeutics Inc

Wall St
Price Targets

Dividends

Entrada Therapeutics Inc
does not pay dividends
Shareholder Yield

Competitive Landscape

Ownership

TRDA Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one TRDA stock?

The intrinsic value of one TRDA stock under the Base Case scenario is 4.37 USD.

Is TRDA stock undervalued or overvalued?

Compared to the current market price of 12.5 USD, Entrada Therapeutics Inc is Overvalued by 65%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett